Evaluation of diseases of the thyroid gland with the vivo use of radionuclides. [/sup 131/I, /sup 99m/Tc, /sup 123/I]

Journal Article · Sat Dec 31 23:00:00 EST 1977 · J. Nucl. Med.; (United States)

OSTI ID:6737049

The thyroid gland is one of the organs frequently studied with nuclear medicine techniques. Over the past several decades, increased attention has been drawn to the association between ionizing radiation and the late development of nodules and cancer of the thyroid gland. Although no association has been reported between diagnostic doses of radiopharmaceuticals and thyroid nodules or cancer, it is advisable to minimize radiation exposure to the thyroid whenever clinical information will not be compromised. Newer radionuclides and techniques yield better diagnostic information, with the delivery of lower radiation doses than techniques commonly used in previous decades. Therefore, recommendations are offered to encourage techniques that reduce radiation dose in thyroid studies with the most commonly used radiopharmaceuticals: (/sup 131/I) sodium iodide, (/sup 99m/Tc) sodium pertechnetate and (/sup 123/I) sodium iodide.

• OSTI ID: 6737049
• Journal Information: J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 19:1; ISSN JNMEA
• Country of Publication: United States
• Language: English

Related Subjects

560161* -- Radionuclide Effects
Kinetics
& Toxicology-- Man
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DISEASES
DOSES
ELECTRON CAPTURE RADIOISOTOPES
ENDOCRINE DISEASES
ENDOCRINE GLANDS
GLANDS
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
IODINE 123
IODINE 131
IODINE ISOTOPES
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIATION DOSES
RADIOISOTOPES
TECHNETIUM 99
TECHNETIUM ISOTOPES
THYROID
THYROIDITIS
YEARS LIVING RADIOISOTOPES